Epileptic spasms in individuals with Down syndrome: A review of the current literature
Open Access
- 16 June 2020
- journal article
- review article
- Published by Wiley in Epilepsia Open
- Vol. 5 (3) , 344-353
Abstract
Epilepsy can occur in individuals with Down syndrome (DS), with epileptic spasms representing the most frequent seizure type in this population. Epileptic spasms can have devastating consequences on the development of individuals with the condition. This review sought to explore the lifetime prevalence and underlying mechanism of epileptic spasms in this population. We also aimed to review the response rate to various treatments, the relapse rate, and the development of subsequent epilepsy or autism in this population. A comprehensive literature search was conducted for articles discussing the lifetime prevalence, diagnosis, treatment, outcomes, or underlying etiology of epileptic spasms in animal models or individuals with DS. According to available literature, the global clinic‐based lifetime prevalence of epilepsy in individuals with DS ranged from 1.6% to 23.1%, with epileptic spasms representing 6.7%‐66.7% of these cases. Response rate to treatment with adrenocorticotropic hormone/corticosteroids was highest (81%) and has the most literature supporting its use, with other regimens, including vigabatrin and other antiepileptic drugs, having lower response rates. Epileptic spasms occur more frequently in children with DS than in the general population, though more studies are needed to determine the true lifetime prevalence of epileptic spasms in this population. Generally, children with DS and epileptic spasms tend to be more responsive to treatment and have better outcomes than children with epileptic spasms of unknown etiology (ie, without DS), in terms of response and relapse rates as well as the development of intractable epilepsy (eg, Lennox‐Gastaut syndrome).Keywords
This publication has 65 references indexed in Scilit:
- Basic mechanisms of catastrophic epilepsy – Overview from animal modelsBrain and Development, 2013
- Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis ComplexPLOS ONE, 2013
- Prenatal stress promotes development of spasms in infant ratsEpilepsia, 2011
- Validation of the rat model of cryptogenic infantile spasmsEpilepsia, 2011
- A pulse rapamycin therapy for infantile spasms and associated cognitive declineNeurobiology of Disease, 2011
- The natural history of epilepsy in tuberous sclerosis complexEpilepsia, 2010
- Infantile Spasms: A Critical Review of Emerging Animal ModelsEpilepsy Currents, 2009
- West syndrome associated with mosaic Down syndromeBrain and Development, 2007
- An analysis of epilepsy with chromosomal abnormalitiesBrain and Development, 2005
- Multi-institutional study on the correlation between chromosomal abnormalities and epilepsyBrain and Development, 2005